Ubiquitous
2024-12-13 16:49:11 UTC
Reply
Permalinkelect Donald Trump's pick for Secretary of Health and Human Services Robert
F. Kennedy Jr. might crack down on weight loss drugs like Ozempic.
During Thursday's episode of the ABC talk show, cohost Whoopi Goldberg
unleashed a rant against RFK. Jr. whom she said plans to crack down on the
off-label use of Ozempic by people who want to manage their weight because
Americans are "addicted to drugs and weight loss should come from diet and
exercise."
"Why should a numbers cruncher with no medical background have any say? I
don't understand why you want to be in my business!" Goldberg said, as her
cohosts Alyssa Farah Griffin, Sunny Hostin, and Sara Haines agreed.
The View is upset that RFK Jr. is looking to crack down on the off-
label use of Ozempic to manage their weight. Whoopi scoffs at the
idea that weight loss should come from diet and exercise.
"I don't understand why you want to be in my business!" she whines.
pic.twitter.com/QSETmQRb58
-- Nicholas Fondacaro (@NickFondacaro) December 12, 2024
Goldberg argued that managing weight wasn't just about food and said
sometimes people are "born genetically larger."
"I want to say this to [RFK Jr.] because you're setting folks up for shame,"
Whoopi said. "That's what you're trying ... maybe you don't know you're doing
... I'm going to give you the benefit of the doubt."
"I'm gonna say you don't realize what you do to people when you say [what you
said] because it doesn't work for everybody. I'm going to show you sir,
because I weighed close to 300 pounds less than two years ago and without the
Mounjaro, this would not have happened," she added, before she stood up and
showed off her slimmer physique.
"You cannot take it out of people's hands if it could help," Goldberg
continued. "If we can keep people healthy. If we can get rid of diabetes. If
we can get rid of all the things, cardiovascular, what's wrong with trying to
do that?"
Joy Behar interjected, "Nothing," before Whoopi continued calling out RFK Jr.
and said he was wrong about weight loss drugs.
Drugs to manage weight have become a hot topic as a growing number of people
seek their weight loss benefits.
However, some unpleasant side effects of taking these types of drugs include
gastrointestinal problems, including abdominal pain, nausea, and vomiting.
There is also a potential risk of thyroid tumors and cancer associated with
[Novo Nordisk's] Ozempic, another popular option, according to studies done
with rodents, as The Daily Wire previously reported.
A recent head-to-head study between two popular weight loss drugs, Eli
Lilly's Zepbound and Novo Nordisk's Wegovy, showed that users lost more
weight using Zepbound.
According to the study, which was sponsored by Lilly, people using Zepbound
lost 20.2% of their body weight over 72 weeks, while Wegovy users lost 13.7%.
In pounds, that means Zepbound users lost an average of 50 lbs, while Wegovy
users lost 33.
--
Let's go Brandon!